Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Amount Raised
$715,000
Round Type
Funding Round
Description
On October 8, 2026, bioAffinity Technologies, Inc. entered into a securities purchase agreement with an institutional investor. The agreement involves the sale of 116,545 shares of common stock and pre-funded warrants to purchase up to 536,836 shares of common stock. This funding will support the company’s initiatives in cancer diagnostics and treatment development.
Fundz sees it the moment bioAffinity Technologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
bioAffinity Technologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.